News

Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
Mestag Therapeutics doses first patient in Phase 1 STARLYS solid tumour trial
read more
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics
Protara reports durable 12-month responses for TARA-002 in Phase 2 bladder cancer trial
read more
Clinical & Regulatory,Digital & Data,Drug Discovery & Development
Veristat launches AI biostatistics platform to accelerate clinical trial data readouts
read more
Manufacturing & Supply Chain
Ampersand Capital Partners sells Tjoapack to Alcami in CDMO packaging sector deal
read more
Biotech & Pharma Business,Digital & Data
Turning AI Skeptics into AI Advocates Through High-Integrity Data
read more
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics
AstraZeneca’s Imfinzi recommended by NICE for resectable gastric and gastro-oesophageal junction cancer
read more
Clinical & Regulatory,Digital & Data,Therapeutic Areas
Grow Therapy study finds most patients report meaningful improvement in depression and anxiety symptoms
read more
Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
EPIK Biosciences launches with ketamine pipeline targeting mental health, chronic pain and addiction
read more
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas
Incannex links PSX-001 psilocybin programme to White House push on psychedelic mental health treatments
read more
Clinical & Regulatory,Drug Discovery & Development
Japan pushes AI clinical trials agenda as global pharma leaders gather in Tokyo
read more
Uncategorised
Longitude Prize on ALS awards £2m to AI drug discovery teams
read more
Medical devices
University of Huddersfield wins award for 3D wound training models
read more
Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics
Remepy and Merck KGaA partner on hybrid drug programmes
read more
Clinical & Regulatory,Digital & Data,Drug Discovery & Development
RxLogix launches AI pharmacovigilance platform for adverse event monitoring
read more
Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas
Intellia reports first positive Phase 3 in vivo CRISPR data in hereditary angioedema
read more
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas
NETRIS Pharma Nature publishes pancreatic cancer Phase 1b data showing NP137 survival and surgery gains
read more

Mestag Therapeutics doses first patient in Phase 1 STARLYS solid tumour trial

Protara reports durable 12-month responses for TARA-002 in Phase 2 bladder cancer trial

Veristat launches AI biostatistics platform to accelerate clinical trial data readouts

Ampersand Capital Partners sells Tjoapack to Alcami in CDMO packaging sector deal

Turning AI Skeptics into AI Advocates Through High-Integrity Data

AstraZeneca’s Imfinzi recommended by NICE for resectable gastric and gastro-oesophageal junction cancer

Grow Therapy study finds most patients report meaningful improvement in depression and anxiety symptoms

EPIK Biosciences launches with ketamine pipeline targeting mental health, chronic pain and addiction

Incannex links PSX-001 psilocybin programme to White House push on psychedelic mental health treatments

Japan pushes AI clinical trials agenda as global pharma leaders gather in Tokyo

Longitude Prize on ALS awards £2m to AI drug discovery teams

University of Huddersfield wins award for 3D wound training models

Remepy and Merck KGaA partner on hybrid drug programmes

RxLogix launches AI pharmacovigilance platform for adverse event monitoring

Intellia reports first positive Phase 3 in vivo CRISPR data in hereditary angioedema

NETRIS Pharma Nature publishes pancreatic cancer Phase 1b data showing NP137 survival and surgery gains

main menu

recent posts

University of Huddersfield wins award for 3D wound training models

Remepy and Merck KGaA partner on hybrid drug programmes

RxLogix launches AI pharmacovigilance platform for adverse event monitoring

get connected